15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Compugen, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $5.00 to $6.00, so the covering firms are broadly aligned. The average target of $5.50 sits 132% above the current $2.38. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.09 next quarter toward $-0.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Compugen.
As of Jul, 3 of 3 firms rate CGEN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CGEN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.10 – $-0.07 · 2 analysts · +21% YoY
Next period, 2 analysts expect Compugen to earn $-0.09 a share (range $-0.10 – $-0.07), versus $-0.07 a year earlier. Full-year consensus is $-0.34, growing to $-0.36 the year after.
REVENUE · NEXT QUARTER
$1.3M
Range $0 – $2.5M · 2 analysts · -32% YoY
Revenue is expected to reach $1.3M (range $0 – $2.5M), -32.1% year-over-year. Full-year consensus is $9.4M, rising to $16.0M next year.
Top analysts covering Compugen
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CGEN.
#1
Leland Gershell
Oppenheimer · Rank #254
Buy
$4.00+68.4% to target
Overall win rate
37%
+ Follow
#2
CM
Chad Messer
Lake Street
Buy
$6.00+152.6% to target
Coverage
—
+ Follow
#3
Daina Graybosch
Leerink Partners
Buy
$13.00+447.4% to target
Coverage
—
+ Follow
CGEN stock forecast FAQ
What is CGEN's average 12-month price target?+
The 1 analysts with a live target average $5.50 for Compugen over the next 12 months, ranging from a $6.00 high to a $5.00 low.
Is CGEN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CGEN?+
The Street-high target is $6.00 (Lake Street), and the Street-low is $5.00. The average of all 1 active targets is $5.50.
How many Wall Street analysts cover CGEN?+
3 analysts have an active rating on Compugen, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CGEN?+
Among analysts who currently cover CGEN, Leland Gershell of Oppenheimer has the strongest overall Quantellect track record (Rank #254). Their current call is Buy with a $4.00 target.
What is Compugen's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.10 – $-0.07) across 2 analysts. Full-year EPS is projected at $-0.34, rising to $-0.36 the following year.
How much revenue is Compugen expected to report next quarter?+
Consensus revenue is $1.3M (range $0 – $2.5M). Full-year revenue is projected at $9.4M, growing to $16.0M next year.
Have analysts been upgrading or downgrading CGEN lately?+
As of Jul, 3 of 3 firms rate CGEN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
